NO20080088L - Sterkt biotilgjengelige orale forsinkede frigjoringsformer av O-desmetylvenlafaksin - Google Patents
Sterkt biotilgjengelige orale forsinkede frigjoringsformer av O-desmetylvenlafaksinInfo
- Publication number
- NO20080088L NO20080088L NO20080088A NO20080088A NO20080088L NO 20080088 L NO20080088 L NO 20080088L NO 20080088 A NO20080088 A NO 20080088A NO 20080088 A NO20080088 A NO 20080088A NO 20080088 L NO20080088 L NO 20080088L
- Authority
- NO
- Norway
- Prior art keywords
- approx
- desmethylvenlafaxine
- hours
- delayed release
- release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Meget biotilgjengelig oral-enhetsdoseform av O-desmetylvenlafaxin-suksinat (DVS) med en forsinket frigjøring på minst ca. én time og en langvarig frigjøring over multiple timer under tilveiebringelse av en total frigjøring på mer enn ca. 85% i løpet av fra ca. 12 til ca. 14 timer er beskrevet. Ved én utførelsesform har det superbiotilgjengelige DVS-preparat en langvarig frigjøring på ca. to timer og en total frigjøring på mer enn ca. 95% i løpet av fra ca. 12 til ca. 14 timer. Anvendelse av formuleringen ved behandling av depresjon og reduksjon av de gastrointestinale bivirkninger av O-desmetylvenlafaxin (ODV) er også beskrevet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69962305P | 2005-07-15 | 2005-07-15 | |
PCT/US2006/027106 WO2007011619A2 (en) | 2005-07-15 | 2006-07-13 | Highly bioavailable oral delayed release dosage forms of o-desmethylvenlafaxine succinate |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080088L true NO20080088L (no) | 2008-04-02 |
Family
ID=37669348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080088A NO20080088L (no) | 2005-07-15 | 2008-01-07 | Sterkt biotilgjengelige orale forsinkede frigjoringsformer av O-desmetylvenlafaksin |
Country Status (20)
Country | Link |
---|---|
US (1) | US20070014859A1 (no) |
EP (1) | EP1904040A2 (no) |
JP (1) | JP2009501233A (no) |
KR (1) | KR20080025405A (no) |
CN (1) | CN101247791A (no) |
AR (1) | AR054833A1 (no) |
AU (1) | AU2006270315A1 (no) |
BR (1) | BRPI0613484A2 (no) |
CA (1) | CA2612960A1 (no) |
CR (1) | CR9626A (no) |
EC (1) | ECSP088106A (no) |
GT (1) | GT200600307A (no) |
IL (1) | IL188313A0 (no) |
MX (1) | MX2008000666A (no) |
NO (1) | NO20080088L (no) |
PE (1) | PE20070192A1 (no) |
RU (1) | RU2007148195A (no) |
SV (1) | SV2008002612A (no) |
TW (1) | TW200740427A (no) |
WO (1) | WO2007011619A2 (no) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006084058A2 (en) | 2005-02-03 | 2006-08-10 | The General Hospital Corporation | Method for treating gefitinib resistant cancer |
EP1863464B1 (en) * | 2005-03-31 | 2009-11-11 | Wyeth | O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof |
US20080175873A1 (en) * | 2005-06-02 | 2008-07-24 | Biovail Laboratories International S.R.L. | Modified release composition of at least one form of venlafaxine |
WO2007056118A1 (en) | 2005-11-04 | 2007-05-18 | Wyeth | Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272 |
WO2007067501A1 (en) | 2005-12-05 | 2007-06-14 | Wyeth | Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols |
TW200806282A (en) * | 2006-05-05 | 2008-02-01 | Wyeth Corp | Solid dosage formulations |
BRPI0812501A2 (pt) * | 2007-07-12 | 2015-06-16 | Reddys Lab Ltd Dr | O-desmetil venlafaxina |
JP2011500605A (ja) * | 2007-10-16 | 2011-01-06 | アルファファーム ピーティーワイ リミテッド | 制御放出医薬配合物 |
US8022216B2 (en) | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
TR201004720T1 (tr) * | 2007-12-10 | 2010-11-22 | Wyeth Llc | Majör depresif bozukluğun tedavisi için o-desmetil venlafaksin |
EP2915532B1 (en) | 2008-06-17 | 2016-10-19 | Wyeth LLC | Antineoplastic combinations containing hki-272 and vinorelbine |
ES2614912T3 (es) | 2008-08-04 | 2017-06-02 | Wyeth Llc | Combinaciones antineoplásicas de 4-anilino-3-cianoquinolinas y capecitabina |
CN101716168B (zh) * | 2008-10-09 | 2014-09-17 | 北京德众万全医药科技有限公司 | 一种含有去甲文拉法新的盐的药物组合物及其制备方法 |
EP2191822A1 (en) * | 2008-11-26 | 2010-06-02 | LEK Pharmaceuticals d.d. | Controlled release pharmaceutical compositions comprising O-desmethyl-venlafaxine |
EP3000467B1 (en) | 2009-04-06 | 2023-03-01 | Wyeth LLC | Treatment regimen utilizing neratinib for breast cancer |
CN102724962B (zh) | 2009-11-09 | 2017-05-17 | 惠氏有限责任公司 | 包衣药物球状体及其用于消除或减少病症比如呕吐和腹泻的用途 |
BR112012024576A2 (pt) | 2010-03-31 | 2016-05-31 | Wockhardt Ltd | composição farmacêutica de liberação modificada compreendendo desvenlafaxina ou sais da mesma e processo para preparação da dita composição |
CN102085197B (zh) * | 2010-12-14 | 2013-08-14 | 北京万生药业有限责任公司 | 一种文拉法辛缓释制剂及其制备方法 |
MX2013011884A (es) | 2011-04-12 | 2013-11-21 | Lupin Ltd | Composiciones farmaceuticas de liberacion modificada de desvenlafaxina. |
CN111008356B (zh) * | 2019-11-13 | 2023-06-16 | 成都理工大学 | 一种基于WTSVD算法扣除背景的γ能谱集分析方法 |
CN114288273B (zh) * | 2022-02-11 | 2022-10-18 | 桂林华信制药有限公司 | 一种盐酸文拉法辛缓释胶囊及其生产工艺 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6274171B1 (en) * | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
WO2000076955A1 (en) * | 1999-06-15 | 2000-12-21 | American Home Products Corporation | Enantiomers of o-desmethyl venlafaxine |
AR021347A1 (es) * | 1999-10-20 | 2002-07-17 | Cipla Ltd | Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma |
AR039165A1 (es) * | 2002-03-28 | 2005-02-09 | Synthon Bv | Venlafaxina base |
US6703044B1 (en) * | 2002-10-25 | 2004-03-09 | Dexcel Pharma Tech, Ltd | Venlafaxine formulations |
DE60309565T3 (de) * | 2003-05-02 | 2015-01-15 | Dexcel Ltd. | Tablettenzubereitung mit verlängerter Freisetzung von Venlafaxin |
CA2554559A1 (en) * | 2004-02-06 | 2005-08-25 | Wyeth | Multiparticulate o-desmethylvenlafaxine salts and uses thereof |
US8394409B2 (en) * | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
-
2006
- 2006-07-13 TW TW095125660A patent/TW200740427A/zh unknown
- 2006-07-13 EP EP06787061A patent/EP1904040A2/en not_active Withdrawn
- 2006-07-13 AR ARP060103012A patent/AR054833A1/es unknown
- 2006-07-13 JP JP2008521581A patent/JP2009501233A/ja not_active Withdrawn
- 2006-07-13 SV SV2006002612A patent/SV2008002612A/es unknown
- 2006-07-13 CA CA002612960A patent/CA2612960A1/en not_active Abandoned
- 2006-07-13 PE PE2006000833A patent/PE20070192A1/es not_active Application Discontinuation
- 2006-07-13 KR KR1020087001067A patent/KR20080025405A/ko not_active Application Discontinuation
- 2006-07-13 US US11/486,324 patent/US20070014859A1/en not_active Abandoned
- 2006-07-13 AU AU2006270315A patent/AU2006270315A1/en not_active Abandoned
- 2006-07-13 CN CNA2006800258002A patent/CN101247791A/zh active Pending
- 2006-07-13 MX MX2008000666A patent/MX2008000666A/es not_active Application Discontinuation
- 2006-07-13 GT GT200600307A patent/GT200600307A/es unknown
- 2006-07-13 RU RU2007148195/15A patent/RU2007148195A/ru unknown
- 2006-07-13 WO PCT/US2006/027106 patent/WO2007011619A2/en active Application Filing
- 2006-07-13 BR BRPI0613484A patent/BRPI0613484A2/pt not_active IP Right Cessation
-
2007
- 2007-12-20 CR CR9626A patent/CR9626A/es not_active Application Discontinuation
- 2007-12-20 IL IL188313A patent/IL188313A0/en unknown
-
2008
- 2008-01-07 NO NO20080088A patent/NO20080088L/no not_active Application Discontinuation
- 2008-01-14 EC EC2008008106A patent/ECSP088106A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR054833A1 (es) | 2007-07-18 |
WO2007011619A3 (en) | 2007-06-21 |
GT200600307A (es) | 2008-04-24 |
CN101247791A (zh) | 2008-08-20 |
US20070014859A1 (en) | 2007-01-18 |
BRPI0613484A2 (pt) | 2016-11-16 |
CA2612960A1 (en) | 2007-01-25 |
TW200740427A (en) | 2007-11-01 |
IL188313A0 (en) | 2008-04-13 |
MX2008000666A (es) | 2008-03-13 |
EP1904040A2 (en) | 2008-04-02 |
JP2009501233A (ja) | 2009-01-15 |
RU2007148195A (ru) | 2009-08-20 |
ECSP088106A (es) | 2008-02-20 |
CR9626A (es) | 2008-04-10 |
KR20080025405A (ko) | 2008-03-20 |
AU2006270315A1 (en) | 2007-01-25 |
SV2008002612A (es) | 2008-08-29 |
WO2007011619A2 (en) | 2007-01-25 |
PE20070192A1 (es) | 2007-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20080088L (no) | Sterkt biotilgjengelige orale forsinkede frigjoringsformer av O-desmetylvenlafaksin | |
SE0501556L (sv) | Förstärkt absorption | |
CA3094580C (en) | Oral formulations of cytidine analogs and methods of use thereof | |
WO2007022518A8 (en) | New uses of glucoregulatory proteins | |
UA94390C2 (ru) | Применение производных индолинонов, предназначенных для лечения или предупреждения идиопатического фиброза легких | |
RS51563B (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ROOSUVASTATIN CALCIUM | |
ATE437679T1 (de) | Wässrige antitranspirant formulierung | |
NO20064670L (no) | Galeniske formuleringer av organiske forbindelser | |
WO2006105112A3 (en) | Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people | |
MY146969A (en) | Dpp iv inhibitor formulations | |
WO2007129270A8 (en) | Cosmetic compositions comprising at least one peptide with at least one immobilized aromatic cycle | |
SG165315A1 (en) | Alpha2c adrenoreceptor agonists | |
JO2973B1 (en) | Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol | |
SG178975A1 (en) | Indenone derivative and pharmaceutical composition comprising same | |
WO2009117401A3 (en) | Compositions for site-specific delivery of imatinib and methods of use | |
IL179859A0 (en) | Oral sustained release formulation of tedisamil with gastric retention properties | |
MA33022B1 (fr) | Composition à libération contrôlée pour produire une préparation à libération prolongée contenant de l'udénafil | |
FR2887447B1 (fr) | Utilisation d'un peptide comme principe actif amincissant | |
NZ599521A (en) | Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease | |
BRPI0511125A (pt) | usos de ácido 5,6,7-triidroxieptanóico seus e análogos | |
WO2006048261A3 (en) | Oral solid dosage forms containing a low dose of estradiol | |
TW200640446A (en) | Prophylactic anti-stress agent | |
EP2105149A3 (en) | A human bone paste, its preparation and use | |
CY1114028T1 (el) | Φαρμακευτικες συνθεσεις για τη θεραπεια των ακροχορδωνων | |
ZA200608999B (en) | Human GLP-1 mimetibodies, compositions, methods and uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |